Lumos Pharma, Inc. LUMO
4.34 +4.34
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 2.05M | 1.52M | 230.00K | 168.00K | 0 | |
| 2.05M | 1.52M | 230.00K | 168.00K | 0 | |
| -36.61M | -32.04M | -31.35M | -26.30M | -9.82M | |
| -34.03M | -31.06M | -30.43M | -5.66M | -9.71M | |
| -4.18 | -3.71 | -3.65 | -0.93 | -9.79 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 35.08M | 56.01M | 94.81M | 98.68M | 4.95M | |
| 40.64M | 72.29M | 100.31M | 129.03M | 5.53M | |
| 13.33M | 12.71M | 11.34M | 12.46M | 1.45M | |
| 585.00K | 233.00K | 557.00K | 319.00K | 380.00K | |
| 27.30M | 59.58M | 88.98M | 116.57M | -59.46M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -31.09M | -26.62M | -29.65M | -23.00M | -9.09M | |
| 10.74M | -11.36M | 25.97M | 116.65M | -2.00K | |
| -576.00K | -821.00K | -192.00K | 75.00K | 22.00K | |
| -20.93M | -38.80M | -3.87M | 93.73M | -9.07M |